The results of a large clinical trial suggest the obesity medication could also change the landscape of cardiovascular care.
The obesity medication contains tirzepatide, the same active ingredient in the diabetes drug Mounjaro.
Drug companies are making billions from a new class of in-demand weight-loss treatments. But the prices are not what they seem.
Many employers and government programs won’t cover costly obesity medications. A lawsuit is challenging one such policy.
The drug Wegovy eased issues for people with a type of heart problem, adding to the treatment’s benefits beyond weight loss.
The empty auditoriums, Gila monsters, resistant pharmaceutical executives and enigmas that led to Ozempic and other drugs that may change how society thinks about obesity.
A clinical trial was the first to demonstrate that a new obesity drug could also improve patients’ heart health.
Many patients say they avoid sweets to help fight the disease. But while a healthy diet is important, you can’t “starve a tumor.”
Una investigación publicada el domingo evalúa la efectividad del ingrediente activo en los medicamentos inyectables para la diabetes y la obesidad cuando se toman por vía oral.
Research published Sunday evaluates the effectiveness of the active ingredient in injectable diabetes and obesity drugs when taken orally.